Page last updated: 2024-08-17

nadp and Carcinoma, Non-Small Cell Lung

nadp has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Bao, M; Chen, Y; Wu, L1
Guo, Y; Huang, D; Ran, M; Tam, KY; Zhang, SL; Zhou, Y1
Boyle, TA; DeNicola, GM; Falzone, A; Kang, YP; Ward, NP1
Bai, X; Jia, W; Liu, Y; Liu, Z; Tang, C; Wang, W; Wu, Y; Yang, H; Yang, Y; Zhang, H; Zhang, J1
Curbo, S; Karlsson, A; Krishnan, S; Paredes, JA; Zhou, X1
Chakrabarti, G1
Hong, KM; Jang, H; Kang, JH; Kim, SY; Lee, C; Lee, JS; Lee, SH; Nam, B; Seong, TW; Son, J1

Other Studies

7 other study(ies) available for nadp and Carcinoma, Non-Small Cell Lung

ArticleYear
MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.
    Molecular biotechnology, 2023, Volume: 65, Issue:5

    Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Metalloproteases; MicroRNAs; NADP; Oxidoreductases; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinones

2023
Cytosolic malic enzyme and glucose-6-phosphate dehydrogenase modulate redox balance in NSCLC with acquired drug resistance.
    The FEBS journal, 2023, Volume: 290, Issue:19

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gefitinib; Glucosephosphate Dehydrogenase; Humans; Lung Neoplasms; NADP; Oxidation-Reduction

2023
Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function.
    The Journal of experimental medicine, 2020, 06-01, Volume: 217, Issue:6

    Topics: Aconitate Hydratase; Animals; Antioxidants; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Catalase; Cell Line, Tumor; Fatty Acids; Iron-Sulfur Proteins; Lung Neoplasms; Mice, Inbred C57BL; Mitochondria; NADP; NADP Transhydrogenases; Oxidants; Oxidation-Reduction; Oxidative Stress; Thioredoxins

2020
Antrodin C, an NADPH Dependent Metabolism, Encourages Crosstalk between Autophagy and Apoptosis in Lung Carcinoma Cells by Use of an AMPK Inhibition-Independent Blockade of the Akt/mTOR Pathway.
    Molecules (Basel, Switzerland), 2019, Mar-12, Volume: 24, Issue:5

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; Maleimides; Microsomes, Liver; NADP; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases

2019
The mitochondrial carrier SLC25A10 regulates cancer cell growth.
    Oncotarget, 2015, Apr-20, Volume: 6, Issue:11

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Dicarboxylic Acid Transporters; Drug Resistance, Neoplasm; Energy Metabolism; Glutamate Dehydrogenase; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; L-Lactate Dehydrogenase; Lung Neoplasms; Mitochondria; Mitochondrial Membranes; NADP; Oxidation-Reduction; Oxidative Phosphorylation; Oxidative Stress; Protein Transport; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering

2015
Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer.
    Radiation oncology (London, England), 2015, Jul-16, Volume: 10

    Topics: Animals; Aspartate Aminotransferase, Cytoplasmic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Databases, Factual; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, ras; Glutamine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Malate Dehydrogenase; Mice; Mice, Transgenic; Mutation, Missense; NADP; Neoplasm Proteins; Oxidation-Reduction; Point Mutation; Prognosis; Radiation Tolerance; Recombinant Fusion Proteins; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Tumor Stem Cell Assay; Up-Regulation

2015
Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
    Oncotarget, 2016, Aug-02, Volume: 7, Issue:31

    Topics: Action Potentials; Adenosine Triphosphate; Aldehyde Dehydrogenase; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytosol; Female; Gossypol; Humans; Lung Neoplasms; Malates; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; NAD; NADP; Neoplasm Transplantation; Oxidative Phosphorylation; Oxidoreductases Acting on CH-NH Group Donors; Phenformin; RNA, Small Interfering

2016